New
Retatrutide
by Ponyon
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied for its roles in metabolic regulation, energy balance, glucose metabolism, and weight-management-related mechanisms.
$62.00
1
SKU RETATRUT-5MG_10 · 30-day returns
Retatrutide is an investigational multi-receptor agonist designed to activate three metabolically relevant signaling pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
Through its activity across these three receptor systems, Retatrutide is studied in research involving appetite and energy-intake regulation, glucose metabolism, lipid metabolism, energy expenditure, and body-weight-related metabolic mechanisms. Its multi-target profile has made it an important research compound in metabolic biology, obesity, and related metabolic research.
Retatrutide remains an investigational compound, and its safety and efficacy continue to be evaluated through clinical research.
For laboratory and research use only. Not for human consumption.
Free standard shipping on orders over $50 to the US, Canada, Mexico and Europe. Orders ship within 1 business day.
Not happy? Return it within 30 days for a full refund, even if opened.
Reviews
No reviews yet
Be the first to review this product.
Complete your routine
New
New
New
New
New
New
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before use if you are pregnant, nursing, taking medication or have a medical condition.